Long-term implant fibrosis prevention in rodents and non-human primates using crystallized drug formulations.

MLA

Farah, Shady, et al. “Long-Term Implant Fibrosis Prevention in Rodents and Non-Human Primates Using Crystallized Drug Formulations.” Nature Materials, vol. 18, no. 8, Aug. 2019, pp. 892–904. EBSCOhost, https://doi.org/10.1038/s41563-019-0377-5.

APA

Farah, S., Doloff, J. C., Müller, P., Sadraei, A., Han, H. J., Olafson, K., Vyas, K., Tam, H. H., Hollister-Lock, J., Kowalski, P. S., Griffin, M., Meng, A., McAvoy, M., Graham, A. C., McGarrigle, J., Oberholzer, J., Weir, G. C., Greiner, D. L., Langer, R., & Anderson, D. G. (2019). Long-term implant fibrosis prevention in rodents and non-human primates using crystallized drug formulations. Nature Materials, 18(8), 892–904. https://doi.org/10.1038/s41563-019-0377-5

Chicago

Farah, Shady, Joshua C Doloff, Peter Müller, Atieh Sadraei, Hye Jung Han, Katy Olafson, Keval Vyas, et al. 2019. “Long-Term Implant Fibrosis Prevention in Rodents and Non-Human Primates Using Crystallized Drug Formulations.” Nature Materials 18 (8): 892–904. doi:10.1038/s41563-019-0377-5.